Formulation Development
Ovid Announces Positive Topline Results for the Next-Generation GABA-Aminotransferase Inhibitor
Ovid Therapeutics Inc. recently announced positive topline results from its Phase 1 healthy volunteer study evaluating the safety, tolerability, pharmacokinetic (PK) and pharmacodynamic (PD) activity…
AM-Pharma Completes Enrollment in Phase 2 Study of Ilofotase Alfa for Prevention of Cardiac Surgery-Associated Renal Damage
AM-Pharma B.V. recently announced that it has successfully completed enrollment of patients in its ongoing Phase 2 clinical trial evaluating ilofotase alfa for the prevention…
Bio-Rad Extends Partnership With Gencurix Through Strategic Agreement for Droplet Digital PCR IVD Oncology Kits in Europe
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, and Gencurix, Inc. (KOSDAQ: 229000), a leading…
Draig Therapeutics Announces US FDA Clearance of IND Application for Phase 2 Study for the Treatment of Major Depressive Disorder
Draig Therapeutics recently announces that it will initiate a Phase 2 study of DT-101, a next-generation AMPA receptor positive allosteric modulator (PAM) for Major Depressive…
Sitryx Receives FDA Clearance of IND Application for Atopic Dermatitis Treatment
Sitryx Therapeutics recently announced it has received clearance from the US FDA for its Investigational New Drug (IND) application for SYX-5219, to support the initiation…
Aerska Launches With $21 Million in Financing to Develop RNAi Medicines for Diseases of the Brain
Aerska, a biotechnology company aiming to redefine the treatment of neurological diseases, recently announced it has raised $21 million in seed financing, co-led by Age1,…
RheumaGen Announces Oral Presentation on HLA Gene-Editing Preclinical Data for Lead Autoimmune Disease Program at ACR Convergence 2025
RheumaGen, Inc., a cell and gene therapy company engineering a new class of therapeutics for major autoimmune diseases, today announced that a human leukocyte antigen…
Fortress Biotech & Urica Therapeutics Announce Crystalys Therapeutics’ $205 Million Series A Financing
Urica Therapeutics, Inc., a Fortress Biotech, Inc. subsidiary, recently announced Crystalys Therapeutics, Inc., in which Urica maintains an equity position, closed a $205 million Series…
VERAXA Biotech & Secarna Pharmaceuticals Initiate Antibody Oligonucleotide Conjugate Alliance in Immunology
VERAXA Biotech, an emerging leader in designing novel cancer therapies and proposed de-SPAC acquisition target of Voyager Acquisition Corp. and Secarna Pharmaceuticals GmbH & Co. KG,…
Sharp Appoints Samantha Wilson Jones as General Counsel
Sharp Services, a leader in pharmaceutical packaging, clinical trial services & sterile manufacturing, has appointed Samantha Wilson Jones as General Counsel and Corporate Secretary of…
Orexo US Awarded $8 Million by BARDA for OX390 Development Partnership
Orexo AB recently announced its wholly owned US subsidiary, Orexo US, Inc., has been awarded USD 8 million in funding by the Biomedical Advanced Research…
Navigating the Fill Finish Process - e-book
You’re here, likely because you are seeking formulation, sterilization, and filling services for your drug. Our guide maps out the journey from onboarding to batch release and highlights facility differences between CMOs so you can understand the impact on your product quality and safety. So, let’s get started!
Credence MedSystems & SMC Ltd. Pharma Services Announce Collaboration to Advance Dual Chamber Fill-Finish Capabilities
Credence MedSystems, Inc. (Credence), an innovator in advanced injectable delivery systems that solve unmet market needs for the pharmaceutical industry, and SMC Ltd. Pharma Services…
Harrow to Acquire Melt Pharmaceuticals
Harrow recently announced it has entered into an agreement to acquire Melt Pharmaceuticals, Inc., a clinical-stage pharmaceutical company pioneering non-opioid, non-IV therapies for sedation for…
Gattefossé Inaugurates New Manufacturing Facility in Texas
Gattefossé, a leading provider of specialty ingredients and formulation solutions for personal care and pharmaceutical industries, celebrated the grand opening of its new manufacturing facility…
AIM ImmunoTech Secures Patent Through 2039 for Novel Cancer Therapy
AIM ImmunoTech Inc. recently announced the Japan Patent Office has issued a patent covering the Company’s proprietary use of Ampligen (Rintatolimod) in combination with checkpoint…
Immuneering Announces Extraordinary 86% Overall Survival at 9 Months in First-Line Pancreatic Cancer Patients Treated With Atebimetinib + mGnP
Immuneering Corporation recently announced positive updated survival and safety data from its ongoing Phase 2a trial of atebimetinib (IMM-1-104) in combination with modified gemcitabine/nab-paclitaxel (mGnP)…
Arecor Announces Co-Development Agreement With US Insulin Pump Device Company
Arecor Therapeutics plc has recently signed a co-development agreement with Sequel Med Tech LLC, a company developing state-of-the-art insulin delivery technologies, to combine AT278 (500U/mL)…
Hovione & Microinnova Partner to Advance Modular Flow Chemistry for Multi-Purpose Manufacturing
Hovione recently announced a partnership to advance the development of multi-purpose, plug-and-play modular equipment for flow chemistry. The companies will work together to test Microinnova’s…
eXmoor Pharma & Siam Bioscience Form Strategic Partnership to Establish Leading Cell & Gene Therapy Services
eXmoor Pharma and Siam Bioscience recently announced a strategic partnership to build the region’s foremost centre for Cell and Gene Therapy (CGT) development and manufacturing.…